Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy

被引：5

作者：

Zhu, Bizhen ^{[1
]}

Huang, Jianping ^{[1
]}

机构：

[1] Peking Univ, Dept Pediat, Hosp 1, Beijing 100034, Peoples R China

来源：

PEDIATRIC NEPHROLOGY | 2011年 / 26卷 / 04期

关键词：

Proteinuria; Nephrotic Syndrome; Glomerular Basement Membrane; CD20 mRNA; Antineutrophil Cytoplasmic Antibody;

D O I：

10.1007/s00467-010-1671-2

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：637 / 638

页数：2

共 4 条

[1]

Cohen CD, 2005, J NEPHROL, V18, P328

[2] Rituximab treatment of idiopathic membranous nephropathy [J].

Fervenza, F. C. ;

Cosio, F. G. ;

Erickson, S. B. ;

Specks, U. ;

Herzenberg, A. M. ;

Dillon, J. J. ;

Leung, N. ;

Cohen, I. M. ;

Wochos, D. N. ;

Bergstralh, E. ;

Hladunewich, M. ;

Cattran, D. C. .

KIDNEY INTERNATIONAL, 2008, 73 (01) :117-125

[3] Idiopathic membranous nephropathy in children [J].

Lee, Beom Hee ;

Cho, Hee Yeon ;

Kang, Hee Gyung ;

Ha, Il Soo ;

Cheong, Hae Il ;

Moon, Kyung Chul ;

Lim, In Seok ;

Choi, Yong .

PEDIATRIC NEPHROLOGY, 2006, 21 (11) :1707-1715

[4] Rituximab for idiopathic membranous nephropathy [J].

Remuzzi, G ;

Chiurchiu, C ;

Abbate, M ;

Brusegan, V ;

Bontempelli, M ;

Ruggenenti, P .

LANCET, 2002, 360 (9337) :923-924

← 1 →